GEP20012357B - Pharmaceutical Product “Phloranormi”
- Google Patents
Pharmaceutical Product “Phloranormi”
Info
Publication number
GEP20012357B
GEP20012357BGEAP20005298AGEAP2000005298AGEP20012357BGE P20012357 BGEP20012357 BGE P20012357BGE AP20005298 AGEAP20005298 AGE AP20005298AGE AP2000005298 AGEAP2000005298 AGE AP2000005298AGE P20012357 BGEP20012357 BGE P20012357B
Authority
GE
Georgia
Prior art keywords
lactobacillus
phloranormi
pharmaceutical product
streptococcus
coli
Prior art date
Application number
GEAP20005298A
Inventor
Leila Kalandarishvili
Original Assignee
Leila Kalandarishvili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leila KalandarishvilifiledCriticalLeila Kalandarishvili
Priority to GEAP20005298ApriorityCriticalpatent/GEP20012357B/en
Publication of GEP20012357BpublicationCriticalpatent/GEP20012357B/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
1. Technical Result Increase in treatment efficiency, simplification of reception and storage. 3. Essence There is obtained bacterial preparation containing the following microorganisms: Bifidobacterium bifidum l, Bifidiobacterium longum, Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus fermenti, Lactobacillus plantarum, Streptococcus faecium, Streptococcus thermophilus, E.Coli M-17 in therapeutically effective amount, as well as tablets and/or capsules, which contain the mentioned microorganisms together with the respective fillers. 3. Field of Application Medicine, therapy.